Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.

@article{LoewBaselli2009SeropersistenceOT,
  title={Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.},
  author={Alexandra Loew-Baselli and E Poellabauer and Borislava G. Pavlova and Sandor Fritsch and Manuela Koska and Roman Bobrovsky and Ryszard Konior and Hartmut J. Ehrlich},
  journal={Human vaccines},
  year={2009},
  volume={5 8},
  pages={551-6}
}
A clinical study was carried out to evaluate the persistence of tick-borne encephalitis (TBE) antibodies 2 and 3 years after a primary vaccination series (three-dose regimen), and to assess the antibody response to a booster vaccination with FSME-IMMUN. Volunteers (N = 347, 18-67 years) who had received two doses of either FSME-IMMUN or Encepur adults and a third vaccination with FSME-IMMUN were enrolled. Seropositivity rates were assessed by ELISA and neutralization test (NT). After the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…